The GCSA Global Advisory Board
The GCSA Global Quality Standard for Clinical Research Sites was developed with a Global Advisory Board (GAB) formed in 2020 of clinical research industry stakeholders (sponsors, CROs, Government & Regulatory organizations, NHS Trusts and commercial site organizations. Their shared ambition is to ensure process excellence that facilitates synergistic partnerships between sites and sponsors to ensure true patient centricity.
The role of the GAB is:
To raise awareness of the importance and adoption of Global Standards for clinical research sites to improve true patient centricity, quality, and safety.
networks for the adoption of Global Standards for clinical
research sites.
To promote the benefits of GCSA Certification and encourage sponsors and CROs to place their clinical trials with GCSA certified sites.
To encourage broader partnerships and wider opportunities and networking with other sitebodies /organizations.
To provide a ‘Disputes Resolution Committee’(escalation committee) for sites.
Meet our Founding Members of the Global Advisory Board
Elizabeth Edwards
Biomat USA
Samin Saeed
Novartis / ABPI Representative
John Mellelieu
Pfizer
Teresa Allen
HRA (Health Research Authority)
Janet Messer
HRA (Health Research Authority)
Sandra Johnson
MMV (Medicines for Malaria Venture)
Maria Palmer
NHS R&D Forum
Simon Lewis
NHS – London North West University Healthcare
Emer MacSweeney
Re:Cognition Health
Agnieszka Gackowska
Parexel
Karen McIntyre
Syneos Health
Emer MacSweeney
Re:Cognition Health
Agnieszka Gackowska
Parexel
Karen McIntyre
Syneos Health
If you are interested in becoming part of our Standards Advisory Board, or would like to get involved in one of our Taskforces, please contact us Vicki Booth for further information – vbooth@iaocr.com